Studies on human pregnancy-induced insulin-like growth factor (IGF)-binding protein-4 proteases in serum: Determination of IGF-II dependency and localization of cleavage site
D. Byun et al., Studies on human pregnancy-induced insulin-like growth factor (IGF)-binding protein-4 proteases in serum: Determination of IGF-II dependency and localization of cleavage site, J CLIN END, 85(1), 2000, pp. 373-381
Insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4), a consistent
inhibitor of IGF action, is subject to proteolytic cleavage by the IGF-II-d
ependent IGFBP-4 protease. However, regulation of the IGF-II-dependent IGFB
P-4 protease in vivo is not known. As IGFBP proteases are known to be trigg
ered during pregnancy, we systematically evaluated the changes in IGFBP-4 p
roteolysis by serum collected throughout human pregnancy. Results from in v
itro protease assays using recombinant IGFBP-4 revealed that IGFBP-4 proteo
lysis determined in both the presence and absence of exogenous IGF-II signi
ficantly increased during the first and second trimesters and reached a pla
teau by the third trimester. However, in the absence of IGF-II, IGFBP-4 pro
teolysis by pregnancy serum was only observed after prolonged incubation. I
GF-II dose dependently increased IGFBP-4 proteolysis by pregnancy serum, wi
th maximal stimulation observed at a concentration of 0.7 mol/L relative to
IGFBP-4. In contrast, IGF-II at an equimolar dose had little effect on pro
teolysis of recombinant human IGFBP-3, whereas excess IGF-II reproducibly i
nhibited recombinant human IGFBP-3 proteolysis by pregnancy serum. Although
IGF-II enhanced IGFBP-4 proteolysis, results from N-terminal sequence and
mass spectrometric analyses of IGFBP-4 proteolytic fragments demonstrate th
at the cleavage site (Met(135)-Lys(136)) in human IGFBP-4 was not altered b
y IGF-II. Deletion of the residues 121-141 containing this cleavage site bl
ocked IGFBP-4 proteolysis. These findings demonstrate that the increase in
IGFBP-4 proteolysis during pregnancy was accounted for mainly by the IGF-II
-dependent IGFBP-4 proteolysis. Because IGFBP-4 is a potent inhibitor of IG
F actions, it can be speculated that the pregnancy-induced IGFBP-4 protease
s may play an important role in regulating fetal growth.